About Index Trending news
Analyze
Pricing
Rigontec GmbH

Rigontec GmbH

Work at Rigontec GmbH? Add yourself to this profile

Rigontec GmbH

Edit Profile
More info

Elsewhere

Companies in the same industry

Kona Medical, Inc. Kona Medical, Inc. Prosensa Prosensa Adnexus Adnexus OMEICOS Therapeutics GmbH OMEICOS Therapeutics GmbH ReCor Medical ReCor Medical Innara Health Innara Health View Medical View Medical Medidaili Technologies Medidaili Technologies Medical Departures inc. Medical Departures inc. PeerBridge Health PeerBridge Health

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Venture capital (Series A)
€15,000,000
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3
Employees

Unknown size

Locations
HQ
Germany
Headquarters
Added by
via rigontec

Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

Health Science Funding
Rigontec GmbH
Rigontec GmbH
€15,000,000 Venture capital (Series A)
FinSMEs

Rigontec Raises €15M in Third Closing of Series A Funding

Funding Health
Rigontec GmbH
Rigontec GmbH